[et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Hero Section” _builder_version=”3.22″ fb_built=”1″ _i=”0″ _address=”0″ global_module=”772″][et_pb_fullwidth_header title=”News ” subhead=”read more” background_overlay_color=”rgba(0,0,0,0.61)” content_max_width=”550px” _builder_version=”3.29.3″ title_font=”Poppins|700||on|||||” title_text_color=”#edbb5f” title_font_size=”14px” title_letter_spacing=”2px” title_line_height=”1.4em” content_font=”Poppins||||||||” content_font_size=”16px” content_letter_spacing=”1px” content_line_height=”2em” subhead_font=”Playfair Display|700||on|||||” subhead_font_size=”48px” subhead_letter_spacing=”3px” subhead_line_height=”1.4em” background_color=”rgba(255, 255, 255, 0)” background_image=”http:\/\/app-pharma.care\/wp-content\/uploads\/2019\/09\/consultant-06.jpg” parallax=”on” parallax_method=”on” custom_button_one=”on” button_one_border_width=”1px” button_one_border_color=”rgba(255,255,255,0.3)” button_one_border_radius=”0px” button_one_letter_spacing=”1px” button_one_font=”Saira Extra Condensed|600||on|||||” button_one_icon=”%%3%%” button_one_icon_color=”#edbb5f” custom_button_two=”on” button_two_border_width=”1px” button_two_border_color=”rgba(255,255,255,0.3)” button_two_border_radius=”0px” button_two_letter_spacing=”1px” button_two_font=”Saira Extra Condensed|600||on|||||” button_two_icon=”%%3%%” button_two_icon_color=”#edbb5f” module_alignment=”right” min_height=”317px” custom_margin=”|||” custom_padding=”4%||5%|||” button_one_text_color_hover=”#edbb5f” button_two_text_color_hover=”#edbb5f” button_one_bg_color_hover=”rgba(0,0,0,0)” button_two_bg_color_hover=”rgba(0,0,0,0)” _i=”0″ _address=”0.0″ button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_one_text_color__hover_enabled=”on” button_one_text_color__hover=”#edbb5f” button_two_text_color__hover_enabled=”on” button_two_text_color__hover=”#edbb5f” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_one_bg_color__hover_enabled=”on” button_one_bg_color__hover=”rgba(0,0,0,0)” button_two_bg_color__hover_enabled=”on” button_two_bg_color__hover=”rgba(0,0,0,0)”][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”news” _builder_version=”3.27.4″ custom_margin=”|||” custom_padding=”100px|0px|19px|0px||” fb_built=”1″ _i=”1″ _address=”1″][et_pb_row use_custom_gutter=”on” gutter_width=”4″ _builder_version=”3.25″ animation_style=”fade” _i=”0″ _address=”1.0″][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” _i=”0″ _address=”1.0.0″ custom_padding__hover=”|||”][et_pb_post_title _builder_version=”3.27.4″ title_font=”Playfair Display|700|||||||” title_font_size=”32px” meta_font=”Poppins||||||||” _i=”0″ _address=”1.0.0.0″][\/et_pb_post_title][et_pb_divider color=”#edbb5f” divider_weight=”2px” _builder_version=”3.2″ max_width=”60px” module_alignment=”left” height=”2px” global_module=”350″ saved_tabs=”all” _i=”1″ _address=”1.0.0.1″][\/et_pb_divider][et_pb_text _builder_version=”3.27.4″ text_font=”Poppins||||||||” text_font_size=”16px” min_height=”44px” _i=”2″ _address=”1.0.0.2″]<\/p>\n
MS Pharma, a fast growing pharmaceutical company based in Jordan and operating across the Middle East, Turkey and Africa, announced today that it has entered into an agreement to acquire 100% of the outstanding shares in Genepharm, a leading European pharmaceutical company. Genepharm\u2019s senior management will remain with the business and help guide the company through the next phase of its growth. The transaction is expected to close by the end of April.<\/p>\n
Based in Greece, Genepharm develops, manufactures and out-licenses high-value generic pharmaceutical products. The Company retains a strong portfolio of products and an extensive network of over 223 customers across 70 countries worldwide. Genepharm combines strong R&D capabilities with manufacturing capacity in conventional solids, sterile liquid (oncology) and oncology oral solids. This acquisition will expand MS Pharma\u2019s geographic footprint, allowing the company to reach more patients and customers in Europe and the rest of the world. It will also complement MS Pharma\u2019s existing chronic disease portfolio with the addition of several important products in cardiovascular, CNS and oncology.
The acquisition will allow Genepharm to access MS Pharma\u2019s manufacturing facilities and products portfolio and be part of a group employing over 2000 employees. Genepharm\u2019s portfolio will be strengthened with sterile injectable products and biotechnology candidates and plans are in place to significantly increase the development resources in Athens.<\/p>\n
Mr Ghiath Sukhtian, Chairman of MS Pharma said:
\u201cThis acquisition is highly complementary and synergistic to our business, and marks an important milestone in our growth plans. Genepharm\u2019s management team has built a successful business, and we look forward to supporting them in growing the Genepharm business. We believe this acquisition will enable Genepharm to offer a wider range of products and technologies to its customers in Europe and around the world.\u201d<\/p>\n
Genepharm said:
\u201cWe are excited to be entering into a new phase of growth with MS Pharma. This acquisition will help accelerate Genepharm\u2019s growth plans and will enable the company to offer a wider range of products to its partners and customers\u201d.<\/p>\n
[\/et_pb_text][et_pb_divider color=”#edbb5f” divider_weight=”2px” _builder_version=”3.2″ max_width=”60px” module_alignment=”left” height=”2px” global_module=”350″ _i=”1″ _address=”1.0.0.1″][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Contact” _builder_version=”3.27.4″ custom_padding=”2px|0px|100px|0px||” animation_style=”zoom” global_module=”339″ saved_tabs=”all” fb_built=”1″ _i=”0″ _address=”2″][et_pb_row column_structure=”1_4,1_2,1_4″ _builder_version=”3.27.4″ max_width=”1440px” animation_style=”slide” animation_duration=”1500ms” _i=”0″ _address=”2.0″][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” _i=”0″ _address=”2.0.0″ custom_padding__hover=”|||”][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” _i=”1″ _address=”2.0.1″ custom_padding__hover=”|||”][et_pb_text module_id=”contact” _builder_version=”3.27.4″ text_font=”Work Sans|600|||||||” text_line_height=”2em” header_font=”||||||||” header_2_font=”Suranna|||on|||||” header_2_font_size=”3vw” header_2_line_height=”1.2em” header_3_font=”Raleway|700||on|||||” header_3_font_size=”12px” header_3_letter_spacing=”1.5px” header_3_line_height=”2em” header_4_font=”||||||||” header_2_font_size_tablet=”5vw” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” border_color_all=”#f3f1f2″ locked=”off” _i=”0″ _address=”2.0.1.0″]<\/p>\n
[\/et_pb_text][et_pb_text content_last_edited=”on|desktop” module_id=”contact” _builder_version=”3.27.4″ text_font=”Poppins||||||||” text_font_size=”16px” text_line_height=”1em” header_font=”Poppins||||||||” header_2_font=”Suranna|||on|||||” header_2_font_size=”3vw” header_2_line_height=”1.2em” header_3_font=”Raleway|700||on|||||” header_3_font_size=”12px” header_3_letter_spacing=”1.5px” header_3_line_height=”2em” header_4_font=”||||||||” header_2_font_size_tablet=”5vw” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” border_color_all=”#f3f1f2″ locked=”off” _i=”1″ _address=”2.0.1.1″]<\/p>\n
Albrecht, Prock & Partners AG<\/p>\n
B\u00f6dlistrasse 3c<\/p>\n
CH-6314 Unteraegeri – Zug, Switzerland<\/p>\n
office(at)ca-pp.net<\/p>\n
[\/et_pb_text][et_pb_contact_form email=”office@ca-pp.net” _builder_version=”3.27.2″ custom_button=”on” button_text_color=”#a0a0a0″ border_color_all=”#000000″ _i=”2″ _address=”2.0.1.2″][et_pb_contact_field field_id=”Name” field_title=”Name” _builder_version=”3.16″ _i=”0″ _address=”2.0.1.2.0″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Email” field_title=”Email Address” field_type=”email” _builder_version=”3.16″ _i=”1″ _address=”2.0.1.2.1″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Message” field_title=”Message” field_type=”text” fullwidth_field=”on” _builder_version=”3.16″ _i=”2″ _address=”2.0.1.2.2″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” _i=”2″ _address=”2.0.2″ custom_padding__hover=”|||”][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
MS Pharma, a fast growing pharmaceutical company based in Jordan and operating across the Middle East, Turkey and Africa, announced today that it has entered into an agreement to acquire 100% of the outstanding shares in Genepharm, a leading European pharmaceutical company. Genepharm\u2019s senior management will remain with the business and help guide the company […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/515"}],"collection":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=515"}],"version-history":[{"count":11,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/515\/revisions"}],"predecessor-version":[{"id":775,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/515\/revisions\/775"}],"wp:attachment":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}